abstract
- Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;383:2333-44. 33085857.
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- February 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Aged, 80 and over (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- COVID-19 (MeSH)
- COVID-19 Drug Treatment (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Respiratory Insufficiency (MeSH)
- SARS-CoV-2 (MeSH)
published in
- ACP journal club Journal